MedApp S.A. is a medical technology company headquartered in Kraków, Poland, and publicly listed on the Warsaw Stock Exchange's NewConnect market. Its flagship platform, CarnaLife Holo, converts CT, MRI, and other DICOM imaging into interactive 3D holograms that clinicians can view and manipulate in the sterile field during procedures — replacing the flat monitor beside the table with anatomy rendered in space. The platform is FDA 510(k)-cleared and CE-marked under MDR, and has been deployed in cardiology, cardiac surgery, and interventional procedures across Europe, Latin America, and the Middle East. MedApp USA, its Delaware subsidiary, leads commercialization in the United States.